TAILRD | Heart

What TAILRD | Heart does

TAILRD Heart, Inc. is a private U.S. health technology company that operates an AI-powered cardiovascular care-gap detection platform for health systems. The platform runs 780+ proprietary gap-detection algorithms across six clinical modules — Heart Failure, Electrophysiology, Structural Heart, Coronary Revascularization, Valvular Surgery, and Peripheral Vascular — plus a Clinical Research Assist module for registry abstraction and trial eligibility screening. Each module continuously scans EHR data to identify cardiovascular patients who should be receiving guideline-directed therapy but are not, then routes prioritized worklists and quantified opportunity estimates to the appropriate stakeholders (executives, service-line directors, and clinicians) via role-based dashboards. The platform was co-developed with Mount Sinai Health System, the #2-ranked cardiac hospital in the U.S., and integrates natively via Redox across Epic, Cerner, Meditech, and other major EHRs; all processing occurs within the health system's network boundary with no PHI stored on TAILRD infrastructure, and the platform is deployed on AWS through Aptible's HITRUST CSF certified managed cloud.

The business model is a subscription SaaS platform priced at the enterprise level, with pricing that appears to scale with health system program size (referenced against a 400-bed program benchmark) and module count. Customer engagement begins with a free Program Analytics report that uses CMS benchmark data to estimate gap opportunity within approximately two weeks, without requiring PHI or EHR integration, before progressing to a fully Redox-connected deployment. Distribution is direct enterprise sales to health system leadership, service-line directors, and clinical stakeholders, supported by CEO faculty presence at major cardiovascular conferences (ACC, TCT, AVAM) and MedTech Innovator 2026 Accelerator Cohort selection (Top 4% of 1,835 applicants). The company is headquartered in San Francisco, incorporated as TAILRD Heart, Inc., and operates exclusively in the United States.

Name

TAILRD | Heart

Legal name

TAILRD Heart, Inc.

Website

https://tailrd-heart.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

TAILRD is an AI-powered cardiovascular care-gap detection platform using 780+ algorithms across six disease modules to identify undertreated patients, serving U.S. health systems via EHR-native SaaS deployment co-developed with Mount Sinai.

Ownership category

akta.pro rank

Product category

Cardiovascular AI Analytics Software

NAICS

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821), Computer Systems Design and Related Services (54151)

SIC

Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)

akta.pro secondary industries

Clinical Triage, Care Navigation & Routing Engines (HLALAKAH), Observability Data Platforms (O11y Pipelines, Telemetry Backends) (HDABAJAJ)

Keywords

• Cardiovascular analytics platform
• AI care gap detection
• EHR-native health AI
• Clinical registry automation
• Health system SaaS

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

1. SaaS Platform Subscription: TAILRD operates as a cloud-based SaaS platform deployed via Redox integration within health system environments. The revenue model is subscription-based, with health systems paying for access to the platform across six clinical modules. Pricing is implied to be program-size dependent (referenced against 400-bed program benchmarks). The go-live process follows a phased approach: free analytics first, then EHR-connected platform deployment.

Pricing tiers

Go-to-market motion3 records

Distribution channels1 record

Marketing channels5 records

Core offering

TAILRD is an AI-powered cardiovascular analytics platform that scans EHR data to identify patients with unmet clinical needs across six disease areas (Heart Failure, Electrophysiology, Structural Heart, Coronary Revascularization, Valvular Surgery, Peripheral Vascular). The platform runs 780+ gap-detection algorithms and routes prioritized worklists to executives, service-line directors, and clinicians. It is co-developed with Mount Sinai, deployed EHR-natively via Redox, and hosted on AWS through Aptible's HITRUST-certified cloud.

Product overview

TAILRD is an AI platform for cardiovascular care-gap detection, consisting of a unified platform with six clinical modules (Heart Failure, Electrophysiology, Structural Heart, Coronary Revascularization, Valvular Surgery, and Peripheral Vascular) plus a Clinical Research Assist module. All modules detect therapy gaps, flag missed interventions, and route prioritized worklists to the appropriate clinical teams. The platform is co-developed with Mount Sinai Health System, integrates natively via Redox with major EHR systems (Epic, Cerner, Meditech), and provides role-based views for executives, service-line directors, and care teams.

Differentiator

Problem solved

Functional benefit

Products and services

• Heart Failure Module

Quantifiable outcome

• 20,588 patients identified with care gaps (Heart Failure module)
• +13 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability2 records

Feature10 records

Partnerships

Four partnerships are on record, tiered flagship and core.

• Mount Sinai Health SystemflagshipStrategic or Co-development PartnerMount Sinai Health System is TAILRD's cardiovascular co-development partner and the clinical anchor for the platform's validation and algorithm development. Mount Sinai is the #2-ranked cardiac hospital in the U.S. The partnership is described as deep and ongoing — TAILRD was co-developed with Mount Sinai and the relationship extends beyond a typical customer reference, involving shared clinical pathway validation and algorithm co-development. Mount Sinai's involvement is prominently featured in TAILRD's trust and credibility messaging across the platform overview, recognition section, and partner logos.
• RedoxcoreTechnology or IntegrationRedox is the EHR integration layer for TAILRD's platform. TAILRD scans EHR data via Redox, with all processing occurring within the health system's network boundary and no PHI stored on TAILRD infrastructure. Redox-certified integration enables compatibility with Epic, Cerner, Meditech, and all major EHR platforms. Live deployment is achievable in days through the Redox integration layer. Redox is prominently featured as a Technology Partner in the Recognition & Partners section and is central to TAILRD's EHR-native value proposition and security architecture.
• AptiblecoreTechnology or IntegrationAptible provides TAILRD's cloud infrastructure hosting. TAILRD is deployed on AWS through Aptible's HITRUST CSF certified managed platform, which handles containers, managed PostgreSQL, and networking. TAILRD inherits compliant infrastructure without operating its own data center or on-premise installation. TAILRD's own company-level SOC 2 Type II certification is in progress. Aptible is listed as a Technology Partner in the Recognition & Partners section and is central to TAILRD's security and compliance architecture for health system procurement.
• MedTech InnovatorcoreGTM or Marketing PartnerMedTech Innovator is a leading medtech accelerator that selected TAILRD for its 2026 Accelerator Cohort, ranking it in the Top 4% of 1,835 applicants. The accelerator provides mentorship, industry connections, and investor visibility. TAILRD is featured on MedTech Innovator's website with this recognition. This partnership provides TAILRD with third-party credibility validation, access to the broader medtech ecosystem, and potential investor introductions.

Scale indicators13 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Viz.ai: AI-powered care coordination and clinical workflow platform, originally focused on stroke and expanded into cardiology. Comparable as a clinical AI platform selling into health systems with EHR-integrated workflow routing, multi-stakeholder user interfaces, and a focus on closing time-sensitive care gaps.
• Ultromics: AI echocardiography platform for cardiovascular diagnostics. Comparable as a cardiovascular AI analytics platform selling into health systems with algorithm-driven clinical insight delivery and FDA-cleared diagnostic algorithms.
• Eko Health: AI-enabled cardiac auscultation and digital stethoscope platform with FDA-cleared algorithms. Comparable as a cardiovascular AI company combining device/sensor data with clinical algorithms to support cardiology decision-making in health systems.
• Cleerly: AI-powered coronary CT angiography analytics platform for cardiovascular disease identification. Comparable as a cardiovascular AI SaaS platform targeting health systems and clinicians with algorithm-driven clinical insight delivery, though narrower in scope (coronary-focused vs. TAILRD's six-module breadth).
• Tempus AI: AI-enabled precision medicine platform with cardiovascular clinical data analytics among its therapeutic areas. Comparable as a healthcare AI platform that ingests clinical/EHR data to surface actionable insights for clinicians and health systems, with a similar enterprise SaaS go-to-market.
• Aidoc: AI clinical platform spanning multiple specialties including cardiovascular imaging. Comparable as an enterprise AI platform deployed within health system EHR environments to surface time-sensitive clinical insights, though focused on imaging rather than care gap detection.
• HeartFlow: AI-driven coronary CT-derived FFR analysis for cardiovascular disease diagnosis. Comparable as an enterprise cardiovascular AI platform selling into health systems with clinical decision support, though focused on coronary imaging rather than TAILRD's broader care gap detection approach.

Emerging players

• Cohere Health: AI-driven prior authorization and care management platform targeting payers and providers. Comparable as an emerging healthcare AI platform that uses clinical intelligence to identify gaps and route care decisions, though focused on authorization rather than therapy gap detection.
• Anterior: AI clinical intelligence platform for health plan and provider prior authorization and clinical decision support. Comparable as an emerging AI platform leveraging clinical data to surface care gaps and administrative insights for healthcare enterprises.

Broad incumbents

• Optum (UnitedHealth Group): Diversified healthcare technology and services subsidiary of UnitedHealth Group with analytics, EHR, and care management offerings for health systems and payers. Comparable as a broad incumbent operating in healthcare AI and care management, with capabilities that overlap TAILRD's clinical analytics positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/TAILRD_Heart
• LinkedInlinkedin.com/company/tailrd

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TAILRD | Heart